Picture of Alkaloid AD Skopje logo

ALK Alkaloid AD Skopje Income Statement

0.000.00%
mk flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Annual income statement for Alkaloid AD Skopje, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue11,10312,13212,79414,28916,513
Cost of Revenue
Gross Profit5,1295,4345,7656,4547,575
Selling / General / Administrative Expenses
Research And Development
Other Operating Expenses
Total Operating Expenses9,90210,78611,31512,61914,690
Operating Profit1,2011,3461,4791,6701,823
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes1,1881,3281,4601,6441,786
Provision for Income Taxes
Net Income After Taxes1,0151,1671,3051,4631,577
Minority Interest
Net Income Before Extraordinary Items
Net Income1,0151,1681,3051,4631,577
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1,0151,1681,3051,4631,577
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS7178299281,0411,122
Dividends per Share